SCHEMBL170765

SCHEMBL170765

C=CCCCN1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
RAB9A P51151 1/20 0.50
HPGD P15428 1/20 0.44
DUSP3 P51452 1/20 0.44
MAPK1 P28482 3/20 0.44
HIF1A Q16665 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 2/20 0.43
SIGMAR1 Q99720 3/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
HTR2A P28223 1/20 0.40
SCN1A P35498 1/20 0.40
HTR2B P41595 1/20 0.40
KCNH2 Q12809 1/20 0.40
SCN2A Q99250 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5254606 0.94 KEAP1 (0.52) KEAP1SMN1; SMN2RAB9AHPGDDUSP3
SCHEMBL28720836 0.92 SMN1; SMN2 (0.50) KEAP1SMN1; SMN2RAB9AHPGDDUSP3
SCHEMBL11782938 0.92 SMN1; SMN2 (0.50) KEAP1SMN1; SMN2RAB9AHPGDDUSP3
SCHEMBL9433442 0.92 SMN1; SMN2 (0.50) KEAP1SMN1; SMN2RAB9AHPGDDUSP3
SCHEMBL2595940 0.86 KDM4E (0.46) KEAP1SMN1; SMN2RAB9AHPGDDUSP3
SCHEMBL7977086 0.85 RAB9A (0.54) KEAP1SMN1; SMN2RAB9AHPGDDUSP3
Bromide SCHEMBL28242666 0.84 KDM4E (0.45) KEAP1SMN1; SMN2RAB9AHPGDDUSP3
Hydrochloric Acid SCHEMBL11687169 0.84 GLA (0.45) KEAP1SMN1; SMN2RAB9AHPGDDUSP3
SCHEMBL28868734 0.84
SCHEMBL6408637 0.82 KEAP1 (0.58) KEAP1SMN1; SMN2RAB9AHPGDDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114409941-B Morpholine functionalized polyphenylene ether anion exchange membrane, preparation method thereof and fuel cell 山东瑞博龙化工科技股份有限公司 2022-11-22 CN claimed
CN-114409941-A Morpholine functionalized polyphenylene ether anion exchange membrane and preparation method thereof and fuel cell 山东瑞博龙化工科技股份有限公司 2022-04-29 CN claimed
US-20110300091-A1 TRANSLUCENT DEODORANT STICKS CONTAINING SOLUBILIZED 3,4,4'-TRICHLOROCARBANILIDE THE DIAL CORPORATION (US) 2011-12-08 US claimed
EP-4355433-A1 SUSPENDING POLYMER COMPOSITION AND METHOD OF USE THEREOF ISP Investments LLC (US) 2024-04-24 EP disclosed
US-20240101589-A1 INHIBITORS OF METTL3 EVOTEC INTERNATIONAL GMBH (DE) 2024-03-28 US disclosed
US-20230193160-A1 A SUSPENDING POLYMER COMPOSITION, AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2023-06-22 US disclosed
EP-4157987-A1 A SUSPENDING POLYMER COMPOSITION, AND METHOD OF USE THEREOF ISP Investments LLC (US) 2023-04-05 EP disclosed
WO-2023009315-A1 A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION ISP INVESTMENTS LLC (US) 2023-02-02 WO disclosed
WO-2022266161-A1 SUSPENDING POLYMER COMPOSITION AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2022-12-22 WO disclosed
CN-114409941-B Morpholine functionalized polyphenylene ether anion exchange membrane, preparation method thereof and fuel cell 山东瑞博龙化工科技股份有限公司 2022-11-22 CN disclosed
CN-114409941-A Morpholine functionalized polyphenylene ether anion exchange membrane and preparation method thereof and fuel cell 山东瑞博龙化工科技股份有限公司 2022-04-29 CN disclosed
WO-1998055089-A1 COSMETIC COMPOSITIONS COMPRISING A PROTEINACEOUS MATERIAL AND A POLYOLESTER THE PROCTER & GAMBLE COMPANY (US) 1998-12-10 WO disclosed
US-5843407-A Non-sweating lipsticks THE PROCTER & GAMBLE COMPANY (US) 1998-12-01 US disclosed
WO-1998022075-A2 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-28 WO disclosed
EP-0706365-A4 COSMETIC MAKE-UP COMPOSITIONS PROCTER & GAMBLE (US) 1998-03-25 EP disclosed
US-5688831-A LIQUID CRYSTALS THE PROCTER & GAMBLE COMPANY (US) 1997-11-18 US disclosed
EP-0778765-A1 COSMETIC MAKE-UP COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-06-18 EP disclosed
WO-1996011665-A1 COSMETIC MAKE-UP COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1996-04-25 WO disclosed
EP-0706365-A1 COSMETIC MAKE-UP COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1996-04-17 EP disclosed
WO-1994028860-A1 COSMETIC MAKE-UP COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1994-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101589-A1 INHIBITORS OF METTL3 METTL3, TPMT, DIMT1 KEAP1 1658/4885SMN1; SMN2 3768/4885RAB9A 2084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.